Nomic Bio is a biotechnology company dedicated to making proteomics accessible, scalable, and routine. Utilizing its proprietary nELISA® technology, Nomic delivers large-scale, quantitative, and cost-effective protein data to accelerate discovery, development, and translation. Their end-to-end service combines flexible content, expert support, and analysis-ready outputs, enabling seamless integration of proteomics across all stages of drug and biomarker development. Key Features and Functionality: - nELISA® Technology: A next-generation immunoassay platform that enables massive multiplexing with true flexibility, full quantification, and unmatched cost-efficiency. - Omni 1000: A high-plex solution profiling 1,000 of the most informative proteins, offering absolute quantification at a cost as low as $50 per sample. - Core Panels: Context-specific panels comprising approximately 300 proteins, focusing on critical areas such as inflammation research. - Flex Panels: Customizable panels allowing researchers to select specific proteins from the entire target library without revalidation or production delays. - High Throughput and Rapid Turnaround: Capable of processing tens of thousands of samples per week with turnaround times as fast as one week. Primary Value and User Solutions: Nomic Bio addresses the traditional challenges in proteomics by providing a scalable, flexible, and cost-effective platform for protein profiling. By offering high-throughput, high-fidelity multiplexing, Nomic enables researchers to accelerate drug discovery, biomarker validation, and translational research. Their solutions empower scientists to gain deeper biological insights, make confident decisions, and advance critical drug discovery efforts efficiently.